Layout:
Home > (TSPT, CLNO, TRID, BLTI) Stock Updates by BestOtc.com

(TSPT, CLNO, TRID, BLTI) Stock Updates by BestOtc.com

September 16th, 2011 at 09:02 am








Transcept Pharmaceuticals, Inc. (Nasdaq:TSPT) announced its plan to resubmit to the U.S. Food and Drug Administration (FDA) its New Drug Application (NDA) seeking approval of Intermezzo® (zolpidem tartrate sublingual tablet) for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.

Read full article:http://bestotc.com/18217/stock-alerts/tspt-clno-trid-blti-stock-updates-by-bestotccom/

0 Responses to “(TSPT, CLNO, TRID, BLTI) Stock Updates by BestOtc.com”

Leave a Reply

(Note: If you were logged in, we could automatically fill in these fields for you.)
*
Will not be published.
   

* Please spell out the number 4.  [ Why? ]

vB Code: You can use these tags: [b] [i] [u] [url] [email]